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Abstract
Problem: In home healthcare services, care experience scores are increasingly the strategy for
evaluating the continuity of care to patients who require post-hospital follow up and guidance on
medication management. Clinician understanding of how to use the available medication
education tools impacts how well patients are able to manage their own care.
Context: The organization’s Home Health clinicians have not done well providing medication
education on side effects as evidenced by low survey scores. The focus of the project is
improving the medication education provided to patients and documentation thereof. The project
takes place in a home health microsystem that serves 370 homebound patients.
Intervention: Clinicians were re-educated on the My Medication Matters teach back tool to
improve care practice and standardize documentation of medication side effect education.
Measures: The outcome measure is the percentage of Yes answers to the survey question on
medication side effects education completed by Home Health patients. To establish the baseline,
the data was collected from October 2020 through September 2021. Rolling mean data was
collected over the course of the intervention from January 2022 through April 2022.
Results: The baseline survey score for medication side effects was 68%. After four months of
interventions, the score was 75.7%, an increase of 11.32%. In the fourth month the rolling mean
decreased to 73.3%, a 7.8% increase over baseline.
Conclusion: Consistent medication side effects instruction and documentation using the My
Medication Matters tool raised the survey scores on medication side effects education over the
four-month intervention. Clinicians trained in patient education on medication side effects are
well positioned to encourage home health patients to be part of the care team and support better
health outcomes.
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Improving the safety of using medication is one of The Joint Commission 2022 National
Patient Safety Goals for Home Care (Joint Commission, 2022). Medication safety is important
due to the growing number of people who are prescribed multiple medications, and who have
difficulty managing those medications. Patient familiarity with their medications, which includes
action and side effects, is integral to the goal of using medications safely, and thereby reducing
negative patient outcomes (Joint Commission, 2022).
The 2022 organizational goals for the Home Health department of a large hospital-based
healthcare system in Northern California revolve around care experience scores, including those
for medication safety and medication side effects. Care experience scores are determined from
surveys administered through the Home Health Consumer Assessment of Healthcare Providers
and Systems (HHCAHPS) that are sent to patients after discharge (Centers for Medicare and
Medicaid Services [CMS], 2020). The survey contains 34 questions on the patient’s perception
of the care received, spanning the domains of communication about care, pain and medication
use, care provided by the home health agency and staying informed about care. The data from
HHCAHPS survey is converted to a Star Rating, which reflects the level of positive responses.
The Star Rating is reported to the home health agency and is made publicly available on the
Medicare.gov Home Health Compare website.
A problem for the healthcare system’s Home Health department is a question on the
survey that asks if medication side effects were discussed during the patient’s care by Home
Health clinicians. Home Health’s score on this question was far below the organization’s target,
and the lowest of 18 Home Health departments in the health system’s northern California region.
The low score brought into question the quality of care on medication administration, as well as
depressing the Star Rating on the Home Health Compare website. The quality coordinator, the
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project co-lead for this quality improvement test of change, identified that improving Home
Health clinician’s understanding of medication side effects would be necessary to reach the
Home Health department’s organizational goal and improve the quality of care for Home Health
patients.
Problem Description
A review of the care experience report from October 2020 to June 2021 revealed a score
of 66.8% on Question 14, which asks the patient if medication side effects were discussed during
care. Home Health is at the bottom of the list in the entire northern California region, which
consists of 18 Home Health departments with a median score of 80% and a top score of 91.3%.
As this is a project metric that matters, providing instruction on medication side effects should be
included in every Home Health visit to help identify any potential medication issues, and to
follow the organization’s policy.
A performance improvement team was formed with the rehabilitation supervisor as the
co-lead, a registered nurse (RN) quality coordinator as the co-lead, along with one physical
therapists, one occupational therapist, and two RNs. The physical therapist, occupational
therapist, and RNs all work in the field providing direct patient care. An initial meeting was
conducted to investigate why the scores on Question 14 were low. One key finding offered by an
RN in the field was that the tool My Medication Matters, was not being used correctly or
consistently. My Medication Matters is a tool used with Home Health patients that incorporates
“teach back” as a method to make sure patients comprehend instructions. Research shows
patients comprehend and recall less than half of what their care providers explain to them
(Prochnow et al., 2018). Furthermore, patient education on medications is not provided until
discharge, when it is difficult for patients to understand all their medication information at once.
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For Home Health clinicians, the lack of knowledge on how to use the My Medication Matters
tool impedes presenting information appropriately and properly documenting their instructions to
the patient. One of the nurses on the performance improvement team commented that the roll out
of My Medication Matters was rushed and no subsequent education or reminders followed the
presentation. Based on these findings, the performance improvement team decided to provide reeducation on My Medication Matters and standardized documentation on patient education on
medication side effects. A description of the project is provided in Appendix A Project Charter.
Available Knowledge
PICOT Question
A PICOT question was created to aid in a literature search. The PICOT question asks:
For Home Health patients (P), how does providing education regarding medications (I)
compared to standard care(C) affect the percentage of chart audits (O) in 5 months (T)?
Search Strategy
A literature search was conducted in February 2022 using the database CINAHL with a
date range of 2017 to 2022. Terms searched were medication, side effects, and education. The
CINAHL search yielded 350 articles. The articles were narrowed by eliminating duplicates and
studies that did not directly address medication side effects. The remaining articles were
examined for inclusion of medication education along with medication side effects. Five studies
met the inclusion criteria. The studies were then evaluated using the Johns Hopkins Research
Evidence Appraisal Tool (Dang & Dearholt, 2018). The appraised studies ranged from Level 1
to Level V, with quality ratings A through C.
Review of Evidence
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One study discusses how medication adherence among patients with hypertension is still
a challenge, even after medication education is included in their care (Ampofo et al., 2020). The
study by Ampofo et al. (2020) was a systematic review and meta-analysis of different education
methods in hypertension participants that promote medication adherence. A search was
performed on the databases EMBASE, MEDLINE, PsycINFO, CINHAL, PUBMED, HTA and
Cochrane for studies published between 1999 and 2019. The inclusion criteria were randomized
control studies and observational studies with adults age 18 and above with uncontrolled
hypertension. Twelve studies yielded that fit the study criteria. Results showed improved
outcomes in health literacy and medication adherence when verbal educational interventions
occurred. Participants who received frequent follow ups with medication education showed even
greater improved outcomes for medication adherence and health literacy. Using the Johns
Hopkins Research Evidence Appraisal tool, the study rated Level III Quality B.
According to Bowen et al. (2017), medication education is needed for positive patient
outcomes, but there are limited information on medication education in the hospital and care
transitions. A cross sectional survey was administered to examine nurses’ behaviors and attitudes
towards medication education. Participants in the study were 24 nurses from departments
internal medicine, cardiology and medical surgical. The survey asked questions such as nurses’
views regarding medication education, medication side effect education, and checking for patient
understanding and medication regimen adherence. The outcome showed positive behaviors and
attitudes by the nurses, but revealed a need for education materials to make instructions simpler,
and thus easier for patients to understand. Using the Johns Hopkins Research Evidence Appraisal
tool, the study rated III C.
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In a systematic review of evidence on the potential negative impact of informing patients
about medication side effects, Jose & AlHajri (2018) recommended that patients be given
medication safety information as part of their care. The authors brought up the concern that while
medication side effects information should be provided to patients, could that information affect
patients’ compliance with medication adherence and clinical outcomes? A systematic search in
PubMed and Cochrane libraries for studies published between 1975 and 2017 yielded 2012
studies. These were narrowed down to 17 randomized control trials that fit the inclusion criteria.
The results did not provide sufficient evidence to support a negative impact on medication
adherence and clinical outcomes when medication side effect education was provided to the
study participants. Using the Johns Hopkins Research Evidence Appraisal tool, the study rated
Level I Quality B.
According to Prochnow et al. (2018), patients and caregivers are not sufficiently
informed about new medications. The authors maintained that nurses are well positioned to lead
change that improves medication education. A quality improvement project was conducted using
a teach back tool kit developed by the Ottawa Model of Research Use. The study consisted of 25
registered nurses, 74 patients and 33 caregivers. The registered nurses were observed while
providing education using the teach back tool kit. A survey was administered to the nurses before
and after providing education to the patients to evaluate the nurses’ comfort levels with the tool
kit. Results showed improvement for patients and caregivers recalling medication purpose and
side effects when teach back was used. Using the Johns Hopkins Research Evidence Appraisal
tool, the article rated Level V Quality B.
See et al. (2020) discussed medication safety and how patients perceive risks and benefits
of their prescribed medications. Qualitative data was gathered from an online survey
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administered to 1079 participants who responded to questions on side effects, risks of
medications, and their understanding medication safety. The authors found patients were
unaware of the roles of pharmaceutical companies and government agencies in ensuring
medication safety and of the importance of reporting medication side effects. From the result, the
authors concluded that there is an ongoing need for education on medications, their safety, and
their side effects. Using the Johns Hopkins Research Evidence Appraisal tool, the article rated
Level III Quality B.
The review of the five studies provided a clear picture of the benefits of medication
education. While barriers to medication education exist, evidence shows the overarching goal to
provide information to patients in to encourage involvement in their healthcare is reasonable and
within reach. Evidence supported medication education by nurses, but not by nurses alone.
Other providers who work directly with the patients, for example physicians, pharmacists, and
rehabilitation clinicians also have a role in medication education, providing continuity and restatement of medication education to help patients better understand the medications and use
them safely. The evidence table is shown in Appendix B.
Rationale
The framework selected for the medication side effect project is the Steven Star Model
(Stevens, 2004) with the five steps of discovery, summary, translation, implementation, and
evaluation. The medication side effects PI team has discussed barriers and potential interventions
to improve medication side effects education. One of the proposed interventions is using the My
Medication Matters tool kit, where teach back is the method of instruction. The first step
(discovery) is where research is conducted to look for evidence-based studies to see if teach back
methods would be beneficial. The second step (summary) narrows the evidence to a more

9
manageable quantity. The third step (translation) packages the evidence summary into a form
that considers care standards, time of instruction, and cost. Once completed, planning for step
four (implementation) began. The plan in this step is to re-instruct teach back methods from the
My Medication Matters toolkit, which was poorly introduced a few years ago. After
implementation, in step five (evaluation) the data was reviewed to see if the intervention made a
difference. The Steven Star Model is shown in Appendix C.
Specific Project Aim
The global aim is to improve Home Health’s overall patient survey rating from
three stars to three and a half. The specific project aim is to improve the percentage of the
patient’s response to the HHCAHPS question 14 from 68% baseline to 70% which asks
the patient if medication side effects were discussed during care by May 2022 in the
Home Health department.
Context
The performance improvement project was initiated by examining the Home Health
microsystem using the five Ps (purpose, patients, practice, process, and patterns) to identify gaps
in care and prioritize areas of focus (Godfrey et al., 2003). According to Harris et al. (2018), a
microsystem is the smallest unit on the front line of healthcare delivery systems. The
microsystem is where the quality of care is defined, and the reputation of the organization
created. Being familiar with a microsystem and working towards quality improvement within a
unit affects patient care in the macrosystem.
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Microsystem Assessment
Purpose
The purpose of the Home Health department is to provide direct skilled care that is safe,
individualized, and timely in the patient’s home environment.
Patients
The Home Health department serves a diverse patient population of 370 homebound
patients who require skilled services such as medication management, disease instruction,
infusion, wound care, strengthening, and gait training. The patient population is spread across
three counties with different socioeconomic and age demographics, and distinct cultural and
religious backgrounds.
Practice
The Home Health department of 87 employees is divided into field clinicians and
office/administrative staff. The field clinicians provide direct patient care, and consist of skilled
nurses, physical therapists, occupational therapists, speech therapists, dieticians, medical social
workers, and home health aides. The office/administrative staff follow a chain of command led
by the medical director and service director who oversee both home health and hospice directors.
The Home Health director and the quality director then oversee the quality coordinators,
supervisors, department secretaries, and the data specialist. The office/ administrative staff are a
resource and support for field clinicians to provide safe, quality care to patients.
Process
Home Health uses different processes to provide safe and effective patient care. The
Home Health Policy and Procedure Manual gives an overview of all aspects of care and serves as
a guide for daily practice and operations from home visit requirements to documentation
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requirements. Another guideline that must be followed by Home Health is the set of CMS
guidelines for home health care. Other guidelines and processes in place are more in depth, such
as documentation guides and tip sheets for use of the electronic medical record. Another process
is the use of chart audits and tracer visits to monitor clinician practices.
Patterns
The Home Health department population is characterized by patients with chronic and
acute illnesses that are managed by multiple medications. For this reason, medication education
is a necessity for safe and effective patient care. A pattern identified in Home Health is an
unacceptably low HHCAPS score on medication side effects instruction.
Strengths, Weakness, Opportunities and Threats (SWOT) Analysis
Strengths
A strength of the microsystem is the Home Health clinicians who are motivated to
provide excellent patient care and are receptive to guidance. The Quality team is a resource for
providing guidance on compliance, policies, and best practices. The third strength is the My
Medication Matters tool kit is widely used for medication education and is familiar to the Home
Health clinicians.
Weakness
Supervisors do not consistently hold clinicians accountable for documentation
compliance. Documentation compliance is a lower priority than preparation for the Joint
Commission survey, which is concurrent with project implementation.
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Opportunities
An opportunity is expanding re-education on the My Medication Matters tool kit to other
Home Health departments and hospital departments in the region to improve medication
education in patient care.
Threats
A threat would be an additional Covid-19 surge that would compete for hospital
resources and it would also impede clinicians’ ability to treat their patients. A Covid-19 surge
would be expected to increase the Home Health patient census, thereby exacerbating staffing
issues, including burn out and attrition. SWOT analysis table is shown in Appendix D.
Return of Investment (ROI)
Dalleur et al. (2021) analyzed 534 cases of 30-day readmissions and found that 80 cases
were due to a potentially avoidable adverse drug event. Readmissions are costly and account for
a huge part of the nation’s healthcare spending. According to Weiss & Jiang (2021), writing in an
Agency for Healthcare Research and Quality (AHRQ) statistical brief, determined an average
readmission cost $15,200. Improved medication side effects instruction does not cost nearly as
much as a readmission. Home Health clinicians see the 370 patients on Home Health’s census
from as few as two times per month to as many as 20 times a month, providing many
opportunities to teach medication side effects and avoid readmissions. Published data for home
health services cost of care averaged $5,591 per 60 days of care in 2020 (Medpac, 2022). The
return of investment projection is based on readmission cost avoidance. One readmission
avoidance event would save the healthcare organization macrosystem $9,264. This amount is
derived from $15,200 (cost of readmission) minus $5,591 (cost of home health services/ per
patient/ 60 days) minus $691 (average cost of materials/ 60 days). Even reducing Home Health
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readmissions by 1% (3.7 patients) represents a cost avoidance of $34,862 for 60 days or
$209,172 per year. The budget and return of investment are shown in Appendix E.
Communication Plan
The communication plan for this project included meetings with the Quality Director,
data analyst, and the performance improvement (PI) team. Monthly meetings with the Quality
Director and Data Analyst took place to go over the status of the project and the data. The
Quality Director then presented the metrics to the Continuum Administrator monthly. One to two
meetings per month occurred with the PI team to identify barriers, plan for implementation, and
create education materials. These were then presented to all staff, either during the monthly all
staff meetings or the weekly quality huddles.
Interventions
The interventions for this project were to re-educate the clinicians on the My Medication
Matters tool kit and to standardize documentation for medication side effect education. The first
re-education session was held in January 2022 with a simplified version of the My Medication
Matters tool kit. All Home Health clinicians participated. A follow up session was held in
February 2022 with highlights from the January presentation to reinforce the most important
content. The third education session was held in May 2022 where the updated medication smart
phrase was presented for standardized documentation. Education materials are shown in
Appendix F.
To develop the interventions, the PI team brainstormed how to address the key barrier
regarding the My Medication Matters tool to kick off the start of 2022. The RN quality
coordinator reviewed the previous educational materials and discussed them with the PI team.
The medication education smart phrase used for documentation was incomplete. The smart
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phrase did not prompt the clinician to document the specific medication that was being
instructed. Since the smart phrase did not prompt the clinician to include the specific medication,
the clinicians thought this was not required. The smart phrase was updated to include a prompt
for the specific medication for which instruction was provided.
Study of the Intervention
Once the interventions were identified, measures (outcome, process and balancing) were
chosen to evaluate the test of change. Two Plan- Do- Study- Act (PDSA) cycles were used to
study the interventions as they proceeded. PDSA is a method to test a change using four steps:
planning, doing, studying, and acting (Agency for Healthcare Research and Quality, 2020).
The initial PDSA cycle was with the re-education of the Home Health clinical staff on use
of the My Medication Matters tool kit. The information was well received. Then in February a
presentation of the highlights from the re-education of the My Medication Matters tool kit was
presented to keep medication side effects a focus and to reiterate the instruction previously given.
The data from chart reviews showed that clinicians were documenting medication side effects,
but documentation was incomplete. The specific medication, use of the tool kit, and patient
response to education were not all consistently included in the documentation.
The PI team investigated the current smart phrase and found it to be incomplete. The PI
team informed the regional quality department and asked for the smart phrase to be updated to
include all required elements. Once the smart phrase was updated and approved, a plan to
provide instruction was developed. However, the PI team was not able to present the information
until May 2022 due to cancelled staff meetings. In June 2022, another presentation was made
reiterate the smart phrase documentation requirements.
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Measures
The outcome measure is the percentage of Yes answers to Question 14 on medication side
effects instruction in HHCAHPS surveys completed by Home Health patients. The outcome
measure data are collected through Strategic Healthcare Programs, a vendor that collects,
processes, and presents the data for the Home Health department. The rolling linear mean data
was collected monthly from October 2020 through May 2022. October 2020 through September
2021 data provided the baseline, whereas January 2022 through May 2022 data represented the
test of change.
The first process measure is the percentage of chart audits where clinicians documented
instructing medication side effects. The second process measure is the percentage of Yes answers
to question 40 on the tracer tool, the data for both measures are collected through the Joint
Commission Resources reports. The balancing measure is the number of times that clinicians do
not use the medication education smart phrase in their documentation. This balancing measure
was chosen as the way clinicians document is not expected to change even though re-education
on My Medication Matters was provided. A measurement strategy table is shown in Appendix G.
Ethical Considerations
Providing instruction to patients on medication side effects encourages patient
involvement in their healthcare. Clinicians apply the Jesuit value of cura personalis, where each
patient is assessed as a whole person and address their needs (University of San Francisco, n.d.).
Treating the patient as a whole with respect and a positive attitude allows the patient a better care
experience and addresses any potential problems that could affect the patient’s overall health.
Provision 2 of the American Nurses Association Code of Ethics (2015) states that the nurse’s
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foremost commitment is to the patient, which aligns with the intent of this project to increase
patient satisfaction and heighten engagement in their care.
This project had been approved as a quality improvement project by the University of
San Francisco School of Nursing and Health Professions faculty with consideration of quality
improvement review guidelines and does not require IRB approval. IRB Non-research
Determination form is shown in Appendix H.
Outcome Measure Results
The purpose of this PI project is to improve clinician medication side effects education
and documentation. The outcome measure is the HHCAHPS score for Question 14 medication
side effects education. Outcome measure results are presented for four months of intervention
data, January through April 2022. Data was collected for May 2022, but HHCAHPS scores will
not be available until August 22, at which time the project will have been completed.
The baseline HHCAHPS score for medication side effects was 68%. After one month of
intervention, when clinicians had been re-instructed on the My Medication Matters tool, the
HHCAHPS score was 75.7%, an increase of 7.7 points. A second re-instruction was conducted in
February; the HHCAHPS score remained at 75.7% for March. In April the score was 73.3%. All
scores reflect a positive change, with a mean of 75.5%. Refer to Appendix I.
The results were expected. Evidence from the literature reviewed indicated patients who
receive frequent follow up with medication education have improved outcomes for medication
adherence and health literacy (Ampofo et al., 2020; Prochnow et al., 2018). My Medication
Matters is a validated and effective tool for medication education used widely across the
healthcare organization with positive results. During the implementation, clinicians expressed
appreciation of the guidance and information was well received.
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Summary
The intervention was effective and produced positive results. Clinicians provided
medication education to their patients as evidenced by the change in HHCAHPS scores. Even
though the 5.3 point change may appear small, the change is substantive in the context of
HHCAHPS scores. The specific aim of a 2% increase was exceeded by 275%.
Preparation for The Joint Commission survey commenced as the PI project was initiated,
perhaps explaining the drop in the rolling mean score to 73.3% in April from 75.7% in March.
The PI team was not able to provide the education and reminders to the extent planned due to
canceled all staff meetings in March and April. A surge in Covid-19 also occurred during project
implementation, which imposed staffing constraints and a hold on the project. The medication
side effects PI team plans to continue to provide education and reminders regarding medication
side effects. A next step is to get the clinical supervisors involved in holding the clinicians
accountable for documentation of medication side effects.
One challenge was the difficulty of keeping the field clinicians focused on medication
side effects education and documentation, and not digressing into related areas that the project
did not address such as the reconciliation of medication list. A lesson learned was that
continually restating the goal and the purpose of the test of change was effective in reining the
clinicians back in. Positive feedback and recognition in the all staff meetings motivated the
clinicians to prioritize medication side effects education in their patient visits. The clinicians in
the PI team assumed the role of medication side effects education “champions,” offering
coaching and support to their peers to help overcome the challenges of providing medication side
effects education. The efforts of these champions contributed to the success of the project.
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Conclusion
Clinician lack of knowledge regarding medication side effects education and
documentation had contributed to unacceptably low HHCAHPS scores on medication side
effects education. The purpose of the project was to improve clinician understanding and
documentation of medication side effects through targeted education on My Medication Matters.
The resulting consistent medication side effects instruction to patients raised the HHCAHPS
scores on medication side effects education over the four-month intervention. Clinicians who
provide direct care to home health patients are well positioned to provide patient education and
encourage patients to be part of the care team. While the scope of this project was limited to
medication side effects education, the approach taken with clinicians on patient education and
documentation applies to all aspects of care experience. The approach of re-education and
reminders used in the project interventions could be applied to other HHCAHPS survey
questions on care experience in home health. The medication side effects PI team plans to sustain
the project by continuing to provide education and reminders to Home Health clinicians on
medication side effects.
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Appendix A
Project Charter
Title: Improving Medication Side Effects Documentation and Clinician Understanding in Home
Health
Global Aim: To improve overall patient survey rating from three stars to three and a half
by May 2022 in the Home Health department.
Specific Aim: To improve the percentage of the HHCAHPS question 14 from 68% baseline to
70% which asks the patient if medication side effects were discussed during care by May 2022 in
Home Health department.
Background:
Home Health’s goal for 2022 revolves around care experience scores which is evaluated
using the Home Health Consumer Assessment of Healthcare Providers and Systems
(HHCAHPS) survey that gets sent to patients randomly after discharge. The survey is a
questionnaire with 34 questions based on a patient’s perception of the care received. A problem
area is question number 14 on the survey which asks the patient if medication side effects were
discussed during care. Home Health is challenged on this topic. A review of the facility ranking
report dated October 2020 to June 2021 showed that this Home Health department scored a
linear mean of 66.8 on question 14. Home Health is at the bottom of the list in the whole region.
Medication side effects is a part of the Home Care: National Patient Safety goal 2022 of
improving the safety of using medications (TJC, 2022). Providing instruction regarding
medication side effects should become a routine task during every visit in home health in order
to identify any potential medication issues. By doing this, readmissions with medication issues as
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the primary diagnosis will also be prevented which over all keeps the patients safe from any
medication problems.
Sponsors
NH- Service Director
TB- Site Director
AG- Quality Director

SC, JS, KB & JC- Clinical Supervisors
AA- Quality Coordinator
VS- Data Analyst

Goals
To improve clinician understanding regarding education of medication side effects during home
visits and to provide standardized documentation requirements regarding medication side effects
which includes the following:
1. Re-education regarding the My Medication Matters teach back tool kit
2. Scripting and developing key phrases to use during home visits that include the word
medication side effects
3. Update the current medication education smart phrase to cover required aspects in
documentation

Measures
Measure
Outcome
% of patient surveys that
answered yes to question 14
where home health department
provided education regarding
medication side effects
Process
% of chart audits where
clinicians documented
instructing medication side
effects
% of tracer audits that are
answered yes to question 40
which indicates clinician
provided education regarding
side effects

Data Source

Target

SHP

70%

JCR medical record audit
report
Chart Review-Remote client

91%

JCR tracer visit audit report
Tracer Visits by supervisors

100%
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Balancing
No decrease in the number of
times that clinicians do not use
the smart phrase in their
documentation

Medical record audit

<5/month

Team
KB- PT Lead
KB- RN Quality Coordinator Co Lead
JS- RN supervisor
JO & AD- Two Registered Nurses
TJ- Physical Therapist
CC- Occupational Therapist
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Evidence Table

Study

Design

Sample

Outcome/Feasibility

Ampofo, A. G., Khan, E., &
Ibitoye, M. B. (2020).
Understanding the role of
educational interventions on
medication adherence in
hypertension: A systematic review
and meta-analysis. Heart &amp;
Lung, 49(5), 537-547.

Systema
tic
Review
and
Metaanalysis

12 studies,
4,205
participant
s

There were low to
moderate evidence to
support improvement of
medication adherence
with education
interventions

Bowen, J. F., Rotz, M. E.,
Patterson, B. J., & Sen, S. (2017).
Nurses’ attitudes and behaviors on
patient medication
education. Pharmacy
Practice, 15(2), 930.
https://10.18549/PharmPract.2017.
02.930

Cross
sectiona
l study

Eviden
ce
Rating
III B

Useful in looking into
effects of medication
education interventions

24 nurses

Over 90% of nurses
believed education
regarding new
information such as
medications important.
Useful in seeing how
nurses’ beliefs affect the
way education is
provided regarding
certain topics

III C
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Jose, J., & AlHajri, L. (2018).
Potential negative impact of
informing patients about medication
side effects: A systematic
review. International Journal of
Clinical Pharmacy, 40(4), 806-822.
https://10.1007/s11096-018-0716-7

Systema
tic
Review

17 RCTs

The study
concluded there is not
enough evidence to
support potential
negative impact of
informing patients
about medication side
effects

IB

Useful in
seeing that medication
side effect education
does not impact patient
compliance
Prochnow, J. A., Meiers, S. J., &
Scheckel, M. M. (2019). Improving
patient and caregiver new
medication education using an
innovative teach-back
toolkit. Journal of Nursing Care
Quality, 34(2), 101-106.
https://10.1097/NCQ.00000000000
00342

Quality
Improve
ment

None

See, M., Butcher, B. E., & Banh, A.
(2020). Patient literacy and
awareness of medicine safety.
Oxford University Press (OUP).
https://10.1111/ijpp.12671

Qualitati 1079
ve study Responde
nts

The teach back method
tool kit strengthened
new medication
education

VB

Useful in looking into
different interventions
that have had positive
results

The study provided
insight regarding
patient’s knowledge of
medication safety.
Useful to find out how
literacy affects
medication safety and
adherence

III B
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Steven Star Model
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Appendix D
SWOT Analysis

STRENGTHS
Home Health clinicians are
motivated to provide excellent
patient care, and are receptive to
guidance.
The Quality team is a resource for
providing guidance on compliance,
policies, and best practices.
My Medication Matters tool kit is
widely used for medication
education and is familiar to the
Home Health clinicians.

WEAKNESSES
Supervisors do not consistently hold
clinicians accountable for
documentation compliance.
Documentation compliance is a
lower priority than preparation for
the Joint Commission survey, which
is concurrent with project
implementation.

THREATS
OPPORTUNITIES
An opportunity is expanding reeducation on the My Medication
Matters tool kit to other Home
Health departments and hospital
departments in the region.

Covid-19 surge that would compete
for hospital resources and it would
also impede clinicians’ ability to
treat their patients.
Covid-19 surge would be expected
to increase the Home Health
patient census, thereby
exacerbating staffing issues,
including burn out and attrition.
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Appendix E
Return on Investment/ Budget
Cost avoidance projection is based on reducing the readmission rate from 1% to 0% through
intervention of clinician medication side effects education.
Item Description One readmission 1% readmission/ 1% readmission/
event
60 days
one year
Cost of
$15,200
$56,240
$337,440
Readmission
Cost of Home
$5,591
$20,687
$124,122
Health Services
(60 days)
Cost of materials $691
$691
$4,146
(60 days)
Net cost
$9,264
$34,862
$209,172
Assumption 1: The patient census for home health services is 370. A 1% readmission rate= 3.7
patient.

Month
Cost of Materials
January
$370
February
$296
March
$0
April
$370
May
TBD
4 month total
$1,036
The only out of pocket cost of the project were for printing My Medication Matters booklets.
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Education Materials
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Appendix G
Measurement Strategy
Global Aim: To improve overall patient survey rating from three stars to three and a half
by May 2022 in the Home Health department.
Population Criteria: Clinicians who care for home health patients
Data Collection Method: Data will be obtained from JCR chart and tracer audit reports and
productivity reports to establish a baseline. Once baseline has been obtained reports will be
reviewed monthly until May 2022.
Data Definitions
Data Element
JCR Medical Record Audit Report
JCR Tracer Audit Report
Productivity report
Remote client

Definition
Report for medical record audits from 5 chart
reviews a week
Report for tracer visits that supervisor
complete by visiting a patient with clinicians
Report based on daily productivity of
clinicians in the home health department
Current charting system being used by home
health that is connected to Health Connect

Measure Description
Measure

Measure Definition

% of patient surveys
that answered yes to
question 14 where
home health
department provided
education regarding
medication side
effects

N=# patient surveys
that answered yes to
question 14 where
home health
department provided
education regarding
medication side
effects
D=# total number of
surveys
N=# charts where
clinicians documented

% of chart audits
where clinicians
documented

Data Collection
source
SHP

Goal
70%

JCR report from
91%
Medical record audits

33
instructing
medication side
effects
% of tracer audits
that are answered yes
to question 40 which
indicates clinician
provided education
regarding side effects

instructing medication
side effects
D=# total number of
charts reviewed
N= # charts where
clinicians used the
medication education
smart phrase
D=# total number of
charts reviewed

JCR report from
Tracer visit audits

100%
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IRB Non-research Determination Form
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
STUDENT NAME: Katherine Bales
DATE: 4/5/22
SUPERVISING FACULTY: David Ainsworth
Instructions: Answer YES or NO to each of the following statements:
Project Title:
The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There is
no intention of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
o r group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves implementation of established and tested quality standards
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new untested standards.
The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of colleagues,
students and/ or patients.
If there is an intent to, or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: “ This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board.”

YES

X
X
X

X

X
X
X
X

X

ANSWER KEY: If the answer to ALL of these items is yes, the project can be
considered an Evidence-based activity that does NOT meet the definition of research.

NO
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IRB review is not required. Keep a copy of this checklist in your files. If the answer to
ANY of these questions is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human Research
Committee, Partners Health System, Boston, MA.

STUDENT NAME (Please print): Katherine Bales
________________________________________________________________________
Signature of Student:
______________________________________________________DATE__4/8/22 ____

SUPERVISING FACULTY MEMBER NAME (Please print): David Ainsworth
Signature of Supervising Faculty Member David Ainsworth DATE 4/10/22
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Results

